Patents by Inventor Candace E. Elliott

Candace E. Elliott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMPA-binding human GluR4 receptors
    Patent number: 7071306
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.
    Type: Grant
    Filed: April 15, 2002
    Date of Patent: July 4, 2006
    Assignee: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human GluR3 receptors
    Patent number: 7030221
    Abstract: Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.
    Type: Grant
    Filed: May 21, 2002
    Date of Patent: April 18, 2006
    Assignee: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human GluR4 receptors
    Publication number: 20030053993
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.
    Type: Application
    Filed: April 15, 2002
    Publication date: March 20, 2003
    Applicant: NPS ALLELIX CORP.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human GluR3 receptors
    Publication number: 20030032038
    Abstract: Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.
    Type: Application
    Filed: May 21, 2002
    Publication date: February 13, 2003
    Applicant: NPS Allelix Corporaton
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • Kainate-binding, human CNS receptors of the EAA3 family
    Patent number: 6500624
    Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of the kainate-binding type of EAA receptor, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.
    Type: Grant
    Filed: February 1, 1994
    Date of Patent: December 31, 2002
    Assignee: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • Kainate-binding human CNS receptors of the EAA4 family
    Publication number: 20020168723
    Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors of the kainate-binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.
    Type: Application
    Filed: April 22, 2002
    Publication date: November 14, 2002
    Applicant: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • Ampa-binding human GluR2 receptors
    Patent number: 6441155
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR2B receptor. The receptor is charactereized structurally and the construction and use of cell lines expressing these receptor is disclosed.
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: August 27, 2002
    Assignee: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human GLuR3 receptors
    Patent number: 6413739
    Abstract: Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.
    Type: Grant
    Filed: July 17, 1997
    Date of Patent: July 2, 2002
    Assignee: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human GluR1 receptors
    Patent number: 6406868
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR1B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.
    Type: Grant
    Filed: March 23, 1994
    Date of Patent: June 18, 2002
    Assignee: NPS Allelix Corporation
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • Ampa-binding human GluR3 receptors
    Patent number: 6403323
    Abstract: Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.
    Type: Grant
    Filed: June 8, 1994
    Date of Patent: June 11, 2002
    Assignee: NPS Allelix Corporation
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human GluR2 receptors
    Patent number: 6399313
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR2B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing these receptor is disclosed.
    Type: Grant
    Filed: May 12, 1995
    Date of Patent: June 4, 2002
    Assignee: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • Kainate-binding, human CNS receptors of the EAA4 family
    Patent number: 6376200
    Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors of the kainate-binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.
    Type: Grant
    Filed: May 25, 1994
    Date of Patent: April 23, 2002
    Assignee: NPS Alleix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human GluR4 receptors
    Patent number: 6372488
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 16, 2002
    Assignee: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human gluR4 receptor methods
    Patent number: 6358693
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.
    Type: Grant
    Filed: March 14, 1995
    Date of Patent: March 19, 2002
    Assignee: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • Kainate-binding, human CNS receptors of the EAA5 family
    Patent number: 6333161
    Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors of the kainate-binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.
    Type: Grant
    Filed: January 6, 1994
    Date of Patent: December 25, 2001
    Assignee: NPS Allelix Corporation
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • DNA encoding kainate-binding, human CNS receptors of the EAA5 family
    Patent number: 6322999
    Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors of the kainate-binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: November 27, 2001
    Assignee: NPS Allelix Corp.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human GluR2 receptors
    Patent number: 6040175
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS glutamate receptor, designated the human GluR2B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing these receptor is disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 21, 2000
    Assignee: Allelix Biopharmaceuticals, Inc.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • Kainate-binding, human CNS receptors of the EAA3 family
    Patent number: 6018023
    Abstract: Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of the kainate-binding type of EAA receptor, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 25, 2000
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • Polynucleotides encoding AMPA-binding human GluR4 receptors
    Patent number: 5643785
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.
    Type: Grant
    Filed: June 13, 1994
    Date of Patent: July 1, 1997
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt
  • AMPA-binding human GluR1 receptors
    Patent number: 5610032
    Abstract: Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR1B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.
    Type: Grant
    Filed: June 6, 1994
    Date of Patent: March 11, 1997
    Assignee: Allelix Biopharmaceutical Inc.
    Inventors: Rajender Kamboj, Candace E. Elliott, Stephen L. Nutt